The New Jersey Supreme Court recently made a significant ruling regarding expert testimony in the case of Alison Beavan v. Allergan U.S.A., Inc. (A-53-24), which could impact future product liability cases. The court's decision, delivered on May 27, 2026, addressed the admissibility of expert evidence in a lawsuit where the plaintiff claims to have suffered serious eye injuries due to a defective product manufactured by Allergan. This ruling is crucial for individuals involved in similar legal disputes, as it clarifies the standards for expert testimony in New Jersey courts.
Alison Beavan, the plaintiff, alleges that she sustained severe eye injuries from a defect in Ozurdex, a product manufactured by Allergan. The case revolves around whether the expert testimony presented by Beavan is reliable enough to be admitted in court. The ruling emphasizes the importance of a rigorous evaluation of expert testimony to ensure that juries are presented with credible and scientifically sound evidence.
This case began when Beavan filed a product liability action against Allergan, claiming that a defect in Ozurdex caused her injuries. She designated two experts to testify about the causation of her injuries: Dr. Maziar Lalezary, a retained expert, and Dr. William B. Phillips, her treating physician. Allergan challenged the admissibility of their testimonies, arguing that they were not sufficiently reliable and constituted net opinions, which are not allowed in court.
The trial court initially denied Allergan's motion to exclude the expert testimony and also denied a motion for summary judgment, which would have dismissed Beavan's claims. However, the Appellate Division later reversed this decision, stating that the expert opinions were net opinions and lacked the necessary support to be admissible. This prompted Beavan to appeal to the New Jersey Supreme Court.
In its ruling, the New Jersey Supreme Court stated that the trial court must conduct a rigorous gatekeeping analysis when determining the admissibility of expert testimony, as outlined in the previous case In re Accutane Litigation. Justice Patterson, writing for a unanimous court, emphasized that the trial court must assess both the methodology used by experts and the underlying data supporting their opinions. The court noted, "Accutane mandates that any dispute about the reliability of expert testimony in a civil case be resolved by the trial court, acting as gatekeeper and applying the factors set forth in Accutane if it deems those factors relevant."
The court found that the trial court did not conduct the required gatekeeping inquiry and remanded the case for further proceedings. It ruled that Dr. Lalezary's report provided adequate explanations for his proposed testimony, thereby reversing the Appellate Division's determination that it constituted a net opinion. However, the court did not make a determination regarding Dr. Phillips's testimony, as no report was submitted for review. The court left it to the trial court to decide whether Beavan could submit a written report from Dr. Phillips.
The ruling also addressed the issue of summary judgment, stating that the Appellate Division's reversal of the denial of summary judgment was based on the exclusion of expert testimony. Therefore, the Supreme Court reversed that determination, allowing the parties to seek summary judgment again after the trial court makes its expert admissibility decisions on remand.
This decision has significant implications for future product liability cases in New Jersey. It reinforces the necessity for trial courts to thoroughly evaluate the reliability of expert testimony before allowing it to be presented to a jury. This ruling will affect not only Beavan’s case but also other plaintiffs who rely on expert opinions in their legal battles against large corporations.
Going forward, the trial court will need to conduct the rigorous gatekeeping inquiry as mandated by the Supreme Court. This will involve assessing the methodologies used by the experts and determining if their opinions are based on sufficient evidence. If the trial court allows Dr. Phillips to submit a report, it will then need to decide on the admissibility of his testimony as well.
As for the possibility of an appeal, the case may still be subject to further review depending on the outcomes of the remand proceedings. If either party is dissatisfied with the trial court's decisions regarding expert testimony or subsequent rulings, they may seek to appeal those decisions again.
This ruling not only clarifies the standards for expert testimony in New Jersey but also underscores the importance of scientific rigor in legal proceedings, especially in cases involving complex medical issues. The court's decision reflects a commitment to ensuring that juries are presented with reliable and relevant evidence when making their determinations.